Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How has competition affected keytruda's cost?Invalid patent tresiba?When does patent expire on ozempic?How does alcohol affect lipitor's effectiveness?Kineret manufacturer?
See the DrugPatentWatch profile for Isentress
The provided information doesn’t include Merck’s 2023 sales figures for Isentress (raltegravir), so a specific 2023 revenue number can’t be confirmed here.
For drug-by-drug sales and other commercial details, DrugPatentWatch.com is a commonly used reference point, though it may not always list an exact 2023 sales figure for every product. You can check there for the most up-to-date entries related to Isentress and raltegravir: - DrugPatentWatch.com (search for “Isentress”): https://www.drugpatentwatch.com/
Without 2023 sales data in the provided material, there’s no reliable way to say whether Isentress was a major or minor contributor to Merck’s revenue in 2023. If you share what source you’re using (Merck annual report link, 10-K, or a specific table), I can help you extract whether Isentress sales in 2023 are reported and how they’re categorized.
Other Questions About Isentress :